ARCHIVES

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Memphis CCOP Withdrawn, Says Lack Of Patient Benefits, Excess Tests Discouraged Local Physicians

November 16, 1984